Rejected at 1:36 p.m. Dec, 13, 2024 ] by thomas.holmes
Author: mohannadkh10
Related Note: 1463844532253
Rationale for change

As far as I understand, this refers to the action of ADH on vascular smooth muscle, which is mediated by the V1 receptor, not the V2 receptor
Source: AMBOSS - https://next.amboss.com/us/article/AT0Rt2?q=antidiuretic%20hormone#Zbf62754ce74881b6657f0771bc811fd7

Rejection reason

see comments, correct as is

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Bootcamp::Pharmacology::01_Pharmacodynamics::08_Receptor_Physiology #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::04_Hypothalamic_&_Pituitary::02_ADH,_DDAVP,_ADH_receptor_antagonists #AK_Step1_v12::^Systems::Endocrine::Pharmacology #AK_Step1_v12::#FirstAid::08_Endocrine::05_Pharm::04_Hypothalamic/pituitary_drugs #AK_Step1_v12::#Bootcamp::Pharmacology::01_Pharmacodynamics::07_Membrane_Proteins #AK_Step1_v12::#Physeo::09_Pharm::07_Endocrine::13_ADH-Related_Drugs #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::05_G-protein-linked_second_messengers::*Vasopressin::V2 #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::05_Other_Involuntary_Signaling_Systems #AK_Step1_v12::#OME::PreClinical::Endocrine #AK_Step1_v12::#Pixorize::03_Pharmacology::01_General_Pharm::16_V2_(Vasopressin)_Receptors